Therefore, further experiments, such as functional assays investigating the substrate preferences of WT and GHR-KO PBMCs would be necessary to confirm or reject a difference in the metabolism of GHR-KO CD4+ PBMCs and possible compensatory mechanisms towards hypoglycemia. The gene discussed is CD4; the disease is Hypoglycemia.